Latest in agri tech to be on show at CIMAP
The event will feature live demonstrations of the newly developed e-tractor and e-tiller by CSIR's Central Mechanical Engineering Research Institute, Durgapur, on Thursday.
These machines are initiatives by CSIR to promote eco-friendly and efficient farming practices. "The demonstration will take place at the CSIR-CIMAP campus. State minister (independent charge), department of horticulture, agriculture marketing, agriculture foreign trade and agriculture export, Dinesh Pratap Singh will be present on the occasion," said CIMAP spokesperson Manoj Semwal.
He said the event will also provide a platform for scientists, agricultural universities, innovators, farmers and stakeholders from across UP to witness the capabilities of these electric-powered farm equipment.
"The e-tractor and e-tiller, developed under the aegis of CSIR, represent a significant step towards green technology in agriculture. These machines are designed to reduce carbon emissions, lower operational costs and enhance productivity for Indian farmers.
The technology demonstration aims to create awareness about the benefits of electric farm machinery and encourage its adoption for sustainable agriculture," said Semwal.
He said these machines are designed for zero emissions, low vibrations and ease of use, especially for women farmers. With women-friendly ergonomics and reduced operational costs, the machines align with India's push for green tech and self-reliance in agriculture.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
18 minutes ago
- Economic Times
Nithin Kamath slams flawed comparison between India and US in candid post, says ‘Gambling runs deep in American culture'. Netizens applaud
Agencies Zerodha's Nithin Kamath sparked debate by contrasting India's options trading with the US, cautioning against superficial comparisons. He emphasized that India's market is less leveraged and still developing, unlike the US, which he characterized as having a deep-rooted gambling culture. In a bold and unfiltered post that's making waves across financial circles, Zerodha co-founder Nithin Kamath has challenged what he calls a 'misguided narrative' comparing India's options trading volumes to those of the United States. And he isn't mincing words. Kamath took to social media this week, highlighting stark contrasts in market maturity, investor behavior, and cultural ethos—concluding with a punchline that's hard to ignore: 'Gambling runs deep in American culture.' The remarks, which appear in a now widely circulated LinkedIn post, reflect growing concerns over surface-level interpretations of trading data, especially as India's retail participation in stock markets continues to surge. At the heart of Kamath's argument is the assertion that Indian markets are not dangerously overleveraged, as some analysts and commentators suggest. He notes that most comparisons rely on the sheer number of options contracts traded, without factoring in premiums or actual capital value. 'If anything, India is significantly less leveraged than the US, even taking into account the fact that our markets are 15–20 years behind theirs,' Kamath wrote in his post. To drive home the scale of difference, Kamath pointed out that the margin funding market in the US recently crossed $1 trillion. In India? It's still under $10 billion—just 1% of that. Likewise, while shorting is a trillion-dollar mechanism in the US, India's stock lending and borrowing market remains in its infancy. — Nithin0dha (@Nithin0dha) Kamath's most eyebrow-raising observation, however, came from outside the trading world—sort of. Referring to a bizarre $210 million wager on whether Ukrainian President Volodymyr Zelensky would wear a suit to the NATO summit, Kamath underlined how deeply embedded gambling is in the American psyche. 'From the stock market to sports, casinos, events, lotteries, prediction markets, and crypto, you can bet on anything,' he said. 'Calling the US a gambling society wouldn't be unfair.' Kamath's comments have ignited a spirited conversation online, with many users rallying behind his take. One user wrote, 'We actually cannot compare Indian markets with the US… the biggest companies in the US are still growing fast, but fractional investing will change the Indian market.' Another comment struck an optimistic tone: 'In the US, approximately 62% of the population has stock market investments, whereas in India, it's only 6%. India could be a sleeping giant waiting to awaken.' Other users praised Kamath for drawing attention to the importance of measuring real leverage over superficial contract counts. 'Comparing contract numbers without looking at actual value is like counting cars without checking if they're Ferraris or Fiat Puntos,' one quipped. Kamath's broader point is that while India's markets are evolving rapidly, they are still in a formative phase—and that's no reason to ring alarm bells. He argued that overzealous comparisons with mature markets like the US not only lack nuance but risk misleading retail investors and policymakers alike. 'We're still building basic infrastructure,' another netizen commented. 'Our regulators are right to be cautious given how new retail participation is. Better slow growth than 2008 crashes.' Whether one agrees or disagrees with Kamath's framing, one thing is clear: the story of India's financial markets cannot—and should not—be told through the lens of another nation's gambling habits.
Time of India
20 minutes ago
- Time of India
From stress to serenity: How India's yoga diplomacy can benefit H-1B holders
As someone who has been advocating for knowledge-worker rights since 2004, I've witnessed the H-1B visa issue evolve from online debates to kitchen table discussions and eventually, to the halls of Congress. The uncertainty and anxiety faced by Indian H-1B holders and their families have only intensified with the growing US visa backlog, now a staggering 11.3 million under the Trump administration. The US visa backlog has real-life implications for millions of Indians who have invested in their American dreams. Delays and uncertainty have become a constant source of stress, affecting not just their careers but also their personal lives. As a nation with a significant soft power asset in spiritual diplomacy, India must navigate this complex issue while balancing its strategic autonomy. A Powerful Tool for Cultural Understanding India's spiritual diplomacy, including Yoga diplomacy, can be a potent tool in promoting cultural understanding and cooperation. With International Yoga Day recognised by over 180 countries worldwide, Yoga has become a global phenomenon, promoting Indian heritage and global harmony. Yoga, with its emphasis on mindfulness, breath control, and physical well-being, can help alleviate stress and anxiety, promoting mental health and resilience. By showcasing its rich spiritual heritage and promoting Yoga, India can foster people-to-people connections and build bridges between nations. Creating a Collective Collaborative Ecosystem To harness the benefits of Yoga diplomacy, India can invite Yoga centres across the country to participate in a unified initiative. This ecosystem can be built by partnering with renowned Yoga centres and ashrams to develop and promote Yoga programs tailored to the needs of Indian citizens abroad. Digital platforms like YogaYukt can disseminate Yoga resources, including videos, apps, and online classes, to enhance accessibility and reach a wider audience of over 650,000 volunteers trained through the Yoga Certification Board. Collaborating with research institutions can also help study the benefits of Yoga and meditation for mental health and well-being. Economic Potential The significance of Yoga and Ayurveda extends beyond culture and diplomacy — they also carry major economic potential. As part of the $4 trillion global wellness industry, India has positioned itself as a leading supplier of Ayurvedic products, herbal remedies, and wellness services. Yoga-related tourism, teacher training programs, and international workshops generate revenue and open up employment opportunities. With global trends shifting toward preventive health and natural living, India is increasingly seen as a hub for integrative healthcare — a fusion of tradition and innovation. A Game-Changer for Global Understanding India's collective collaborative effort to promote Yoga diplomacy can be a game-changer in fostering global understanding, cooperation, and peace. By harnessing the power of Yoga and meditation, India can promote its rich spiritual heritage, build bridges between nations, and demonstrate its commitment to the well-being of individuals worldwide. This initiative can not only aid in addressing the challenges faced by Indian citizens abroad but also showcase India's unique cultural identity and promote a positive image of the nation globally. With a 25-million-strong Indian diaspora representing a powerful network of influence across the world, Yoga diplomacy provides a cultural link that strengthens ties between these communities and their homeland. As India continues to navigate complex global issues, its Yoga diplomacy effort can serve as a beacon of hope and cooperation, promoting a more harmonious and peaceful world order. Facebook Twitter Linkedin Email Disclaimer Views expressed above are the author's own.
Economic Times
20 minutes ago
- Economic Times
Healthcare costs in US to shoot up following Trump tariff on Indian goods: Industry experts
Agencies Representative Image New Delhi: Healthcare costs in the US will increase following the imposition of sweeping 25 per cent tariff plus an unspecified penalty on Indian goods, experts from pharmaceuticals and medical devices industry said on Thursday. President Donald Trump on Wednesday announced the imposition of a 25 per cent tariff on all goods coming from India starting August 1, plus an unspecified penalty for buying Russian crude oil and military equipment. Profits for Indian pharmaceutical firms may decline and research and development may stagnate. However, for the medical devices sector as long as the gap between duty on China and India is over 15- 20 per cent, there are positive prospects for exports to the US, according to experts. "India isn't just a key supplier of generics to the US. We are a part of the backbone of affordable global healthcare. These duties may interrupt the smooth trade flow, inflate US drug costs, stall treatments, and put even greater pressure on American healthcare budgets," OmniActive Health Technologies Executive Chairman and MD Sanjaya Mariwala said. On the other hand, he said, "Back home, the profits for Indian pharmaceutical firms may decline, and R&D may stagnate, slowing down innovation and stalling new drug clearances." AiMeD (Association of Indian Medical Device Industry) Forum Coordinator Rajiv Nath said, "Duties impact for Indian medical devices sector has to be seen from relative competitiveness - as long as duty gap between Chinese versus Indian is over 15- 20 per cent, we have positive prospects to export to USA and even put production lines in USA." Currently Indonesia and Vietnam have lower duties by 6 per cent. So for products made there they will possibly enjoy a price competitive advantage over India, he added. Stating that clarity will come after August 12 as then duties on Chinese goods will be clear, Nath said, "They were increased to over 50 per cent but temporarily reduced to 30 per cent. If post-August duties on Chinese medical devices revert to over 50 per cent and on Indian at 25 per cent, the export prospects versus China are in our favour..." He further said, "Suffice to say that whatever is the final duty that is finally announced on medical devices, if it's at least 15-20 per cent lower than applicable duty rates by US onto China then there is a strong opportunity for Indian medical devices to increase their exports to US market, if they are able to absorb the excessive high cost of regulatory approval of USFDA for market entry and find that these costs to export are sustainable over the years." However, he said, the government of India and manufacturers will need to work to improve India's competitiveness "so that we can offset the 6 per cent disadvantage over Indonesian and Vietnam competitors". Grant Thornton Bharat Partner and Tax Controversy Management Leader Manoj Mishra pointed out that the strong language used by President Trump and ongoing investigations into drug imports mean that the risk is not over yet. "Indian pharma companies should stay prepared for possible changes, especially if sector-specific duties are introduced later. That said, these tariffs are likely to be in place only for a short period, as both countries are expected to fast-track discussions for a Bilateral Trade Agreement. A balanced and stable trade deal will be key to protecting long-term interests of the sector," he noted. Similarly, Choice Broking Equity Research Analyst- Pharma Sector, Maitri Sheth said the US remains heavily reliant on India for its pharmaceutical needs, with about 50 per cent of generic drugs sourced from India. "Given the critical nature of healthcare and already elevated healthcare costs in the US, we view the likelihood of material near-term tariffs on pharma as low," Sheth added. While the headline risk persists, the structural dependence on Indian pharma and the cost sensitivity of the US healthcare system provide a strong case against aggressive tariff action on the sector, Sheth added. Medical Technology Association of India (MTaI) Chairman Pavan Choudary said President Trump's is "troubling and seems economically shortsighted and strategically misguided".
